Displaying drugs 626 - 650 of 661 in total
Sulfachlorpyridazine
A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.
Vet approved
Matched Description: … A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine. …
Matched Salts name: … Sulfachlorpyridazine sodium ... Sodium sulfachlorpyridazine monohydrate …
Matched Salts name: … Sulfachlorpyridazine sodium ... Sodium sulfachlorpyridazine monohydrate …
Cefodizime
Experimental
Matched Iupac: … )-4-methyl-1,3-thiazol-2-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid …
Matched Salts name: … Cefodizime sodium …
Matched Salts name: … Cefodizime sodium …
BR-007
Investigational
Matched Iupac: … -2-yl)-4H,5H,6H-pyrrolo[1,2-b]pyrazol-3-yl]quinolin-7-yl}oxy)ethoxy]carbonyl}amino)butyl]phosphonic acid …
Matched Salts name: … BR-007 sodium …
Matched Salts name: … BR-007 sodium …
Rigosertib
Rigosertib has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma, and Neoplasms, among others.
Investigational
Matched Iupac: … 2-[(2-methoxy-5-{[(E)-2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetic acid …
Matched Description: … , and Neoplasms, among others. ... Rigosertib has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma …
Matched Salts name: … Rigosertib Sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … , and Neoplasms, among others. ... Rigosertib has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma …
Matched Salts name: … Rigosertib Sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Denufosol
Denufosol was an inhaled drug used for the treatment of cystic fibrosis (CF), showing various improvements in lung function during a phase III clinical trial. A new drug application (NDA) was filed with the FDA in 2011, however, the second phase III clinical trial showed a lack of improvement in...
Investigational
Matched Iupac: … tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphinic acid …
Matched Description: … Denufosol has not gained FDA approval, and clinical trials with this drug have ceased since 2011. ... The drug was also evaluated in the treatment of retinal detachment and other diseases of the retina. …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Matched Description: … Denufosol has not gained FDA approval, and clinical trials with this drug have ceased since 2011. ... The drug was also evaluated in the treatment of retinal detachment and other diseases of the retina. …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Hyperforin
Hyperforin is a phytochemical generated by the plants of the Hypericum family. One of the most important members of this family, due to its medical properties, is Hypericum perforatum, also known as St John's wort.
Nutraceutical
Eritoran
Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.
Investigational
Matched Iupac: … -11-enamido]-5-(phosphonooxy)oxan-2-yl]oxy}methyl)-3-(3-oxotetradecanamido)oxan-2-yl]oxy}phosphonic acid …
Laquinimod
Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well...
Investigational
Matched Description: … Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries ... It has been shown to reduce disease activity on magnetic resonance imaging and to be well tolerated orally …
Matched Salts name: … Laquinimod sodium …
Matched Salts name: … Laquinimod sodium …
BQ-123
BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.
Investigational
Matched Iupac: … pentaoxo-3-(propan-2-yl)-hexadecahydro-1H-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-12-yl]acetic acid …
Matched Description: … Bypass Grafting, and ST-Elevation Myocardial Infarction. ... BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary …
Matched Salts name: … Bq 123 Sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … Bypass Grafting, and ST-Elevation Myocardial Infarction. ... BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary …
Matched Salts name: … Bq 123 Sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Prednisolone hemisuccinate
Experimental
Matched Iupac: … ,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethoxy}-4-oxobutanoic acid …
Matched Salts name: … Prednisolone sodium succinate …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists …
Matched Salts name: … Prednisolone sodium succinate …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists …
BMS-986020
BMS-986020 is under investigation in clinical trial NCT02017730 (To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers).
Investigational
Matched Iupac: … (1R)-1-phenylethoxy]carbonyl}amino)-1,2-oxazol-5-yl]-[1,1'-biphenyl]-4-yl}cyclopropane-1-carboxylic acid …
Matched Description: … investigation in clinical trial NCT02017730 (To Evaluate The Relationship Between Plasma Drug Levels And …
Matched Salts name: … BMS-986020 sodium …
Matched Description: … investigation in clinical trial NCT02017730 (To Evaluate The Relationship Between Plasma Drug Levels And …
Matched Salts name: … BMS-986020 sodium …
Ifetroban
Ifetroban has been used in trials studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and Scleroderma, Diffuse, among others.
Investigational
Matched Iupac: … ,4R)-3-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl}phenyl)propanoic acid …
Matched Description: … studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and …
Matched Salts name: … Ifetroban Sodium …
Matched Description: … studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and …
Matched Salts name: … Ifetroban Sodium …
Faropenem
Faropenem has been used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and Community Acquired Pneumonia.
Investigational
Matched Iupac: … -[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid …
Matched Description: … Faropenem has been used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and …
Matched Salts name: … Faropenem Sodium …
Matched Description: … Faropenem has been used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and …
Matched Salts name: … Faropenem Sodium …
Uproleselan
Uproleselan is a novel, specific E-Selectin antagonist under investigation in clinical trial NCT02306291 (Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML).
Investigational
Matched Iupac: … -methyloxan-2-yl]oxy}cyclohexyl]oxy}-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}propanoic acid …
Matched Description: … antagonist under investigation in clinical trial NCT02306291 (Study to Determine Safety, Pharmacokinetics and …
Matched Salts name: … Uproleselan sodium …
Matched Description: … antagonist under investigation in clinical trial NCT02306291 (Study to Determine Safety, Pharmacokinetics and …
Matched Salts name: … Uproleselan sodium …
Tenivastatin
Experimental
Matched Iupac: … 2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid …
Matched Salts name: … Tenivastatin sodium …
Matched Salts name: … Tenivastatin sodium …
Cloprostenol
Vet approved
Matched Iupac: … 3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid …
Matched Salts name: … Cloprostenol sodium …
Matched Salts name: … Cloprostenol sodium …
Faldaprevir
Faldaprevir has been investigated for the treatment of Chronic Hepatitis C.
Investigational
Matched Iupac: … cyclopentyloxy)carbonyl]amino}-3,3-dimethylbutanoyl]pyrrolidine-2-amido]-2-ethenylcyclopropane-1-carboxylic acid …
Matched Salts name: … Faldaprevir sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Salts name: … Faldaprevir sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Diquafosol
Experimental
Matched Iupac: … tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphinic acid …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Ozagrel
Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Investigational
Matched Iupac: … (2E)-3-{4-[(1H-imidazol-1-yl)methyl]phenyl}prop-2-enoic acid …
Matched Salts name: … Ozagrel Sodium …
Matched Salts name: … Ozagrel Sodium …
Fiboflapon
Investigational
Matched Iupac: … ethoxypyridin-3-yl)phenyl]methyl}-5-[(5-methylpyridin-2-yl)methoxy]-1H-indol-2-yl]-2,2-dimethylpropanoic acid …
Matched Salts name: … Fiboflapon Sodium …
Matched Salts name: … Fiboflapon Sodium …
Talaporfin
Talaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia.
Investigational
Matched Iupac: … 3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),6,8,10,12,14,16(22),17,19-decaen-2-yl]acetamido}butanedioic acid …
Matched Description: … Talaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia …
Matched Salts name: … Talaporfin Sodium …
Matched Description: … Talaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia …
Matched Salts name: … Talaporfin Sodium …
Muparfostat
Muparfostat (PI-88) is a mixture of highly sulfated, monophosphorylated mannose oligosaccharides, derived from the extracellular phosphomannan of the yeast Pichia (Hansenula) holstii, with potential antiangiogenic activity.
Investigational
Matched Iupac: … methyl]oxan-3-yl]oxy}oxan-4-yl]oxy}-6-[(phosphonooxy)methyl]-4,5-bis(sulfooxy)oxan-3-yl)oxidanesulfonic acid …
Matched Salts name: … Muparfostat sodium …
Matched Salts name: … Muparfostat sodium …
Dersalazine
Investigational
Matched Iupac: … 1H-imidazo[4,5-c]pyridin-1-yl}methyl)piperidin-1-yl]-3-oxo-1-phenylprop-1-en-1-yl]phenyl}diazen-1-yl]benzoic acid …
Matched Salts name: … Dersalazine Sodium …
Matched Salts name: … Dersalazine Sodium …
Reltecimod
Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).
Investigational
Matched Iupac: … methylbutanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-{[(1R)-1-carboxyethyl]carbamoyl}propanoic acid …
Matched Description: … Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study …
Matched Salts name: … Reltecimod sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Costimulatory and Inhibitory T-Cell Receptors …
Matched Description: … Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study …
Matched Salts name: … Reltecimod sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Costimulatory and Inhibitory T-Cell Receptors …
Emeramide
Emeramide has been used in trials studying the treatment of Mercury Poisoning.
Investigational
Matched Salts name: … Emeramide Sodium …
Displaying drugs 626 - 650 of 661 in total